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a  b  s  t  r  a  c  t
The  knowledge-practice  gap in public  health  is  widely  known.  The  importance  of using
different  types  of evidence  for  the development  of effective  health  promotion  has  also
been  emphasized.
Nevertheless, in practice,  intervention  decisions  are  often  based  on perceived  short-term
opportunities,  lacking  the  most  effective  approaches,  thus  limiting  the  impact  of  health
promotion  strategies.  This  article  focuses  on  facilitators  and  barriers  in the  use  of evidence
in developing  health  enhancing  physical  activity  policies.
Data  was  collected  in 2012  by interviewing  86 key  stakeholders  from  six EU  countries
(FI,  DK,  UK,  NL, IT, RO)  using  a common  topic  guide.  Content  analysis  and  concept  mapping
was  used  to construct  a  map  of  facilitators  and  barriers.
Barriers  and facilitators  experienced  by most  stakeholders  and  policy  context  in each
country  are  analysed.  A  lack  of  locally  useful  and  concrete  evidence,  evidence  on  costs,  and
a lack  of joint  understanding  were  speciﬁc  hindrances.  Also  users’  characteristics  and  the
role media  play  were  identiﬁed  as  factors of inﬂuence.
Attention  for individual  and  social  factors  within  the policy  context  might  provide  the  key
to enhance  more  sustainable  evidence  use.  Developing  and  evaluating  tailored  approaches
impacting  on  networking,  personal  relationships,  collaboration  and  evidence  coproduction
is recommended.
©  2017  The  Author(s).  Published  by  Elsevier  Ireland  Ltd.  This  is an  open  access  article
under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
It is well acknowledged that the use of robust evidence
to inform public health policy is likely to ensure the greatest
and most equitable population health gains [1,2]. Increas-
ing focus on evidence-informed public health in which next
to different sources of research evidence contextual fac-
tors also play a substantial role in the decision making
process [3] and has numerous direct and indirect beneﬁts.
Among these are access to more and higher quality infor-
mation on what works, a higher likelihood of successful
programs and policies being implemented, greater work-
force productivity, and more efﬁcient use of resources [4].
Nevertheless, in practice, intervention decisions are often
based on perceived short-term opportunities, lacking sys-
tematic planning and review of the best evidence regarding
effective approaches [4] thus resulting in slow uptake of
research evidence in practice. It has been estimated that it
takes an average of 17 years for 14% of research to trans-
late into practice [5]. More recent results show that even in
clinical practice which is supposed to be more evidence ori-
ented, the uptake of evidence has not changed substantially
since then, indicating that the gap between evidence and
practice has not diminished substantially [6]. Generally in
public health policy making the use of research evidence is
less than anticipated when considering the extensive avail-
ability of research evidence. While research evidence on
effective health enhancing physical activity (HEPA) policies
and interventions is available, it appears not to be opti-
mally used to inform health related policy development
[7–11]. A multitude of factors that impede (or facilitate)
evidence-informed policy making exists resulting in below
optimal health outcomes when implemented. Literature
shows that speciﬁc contexts and traditions, political prior-
ities, individual beliefs and preferences, social values, and
available resources all play a major role [12,13]. Among
these factors three main categories can be distinguished.
Firstly, easy access to relevant and useful research [14]
also entailing timely access to good quality and relevant
research evidence [15]. Secondly, frequent opportunities
to interact with researchers [7] including collaboration
and networking with policymakers [15]. Thirdly, work-
ing in research receptive organizations [16,17] facilitates
evidence-informed policy making.
The updated systematic review on barriers and facili-
tators of evidence use in policy making by Oliver et al. in
2014 [15] concluded that over the past 10 years these have
basically remained the same and that it is difﬁcult to ﬁnd
new perspectives. Some recent research however points
in the direction of personal relationships and policy mak-
ers’ networks as well as differences in contextual factors
to be of utmost importance in relation to improving the
uptake of evidence in policy. Policy makers appear to have
a need for and also use a much wider range of informa-
tion sources than research evidence and they access most
of these through personal contacts [18]. In addition, policy
makers’ relationships within networks and characteristics
of the organizational context such as the much neglected
role of managers in policy decision making appears to be
of great inﬂuence in evidence use [18–22]. Also studies
with empirical data on interactions between stakeholders
in policymaking report that the use of evidence in the pol-
icy process was difﬁcult to trace or that the process itself
appears to be rather closed [23–27].
Furthermore the literature shows that policymakers
with respect to use of evidence need to pay attention
to larger entities and multi-dimensional factors such as
communities, municipalities, resources, politics and other
factors as compared to for instance clinicians [21,28]. This
makes use of evidence by policymakers much more com-
plicated and may  be the reason that the extent of evidence
use by them is lower in comparison to clinicians who focus
on one speciﬁc issue only, i.e. the physical condition of the
individual patient.
Despite several decades of work on evidence informed
policy, the goals to improve evidence uptake and promote
greater use of evidence within policy making are still elu-
sive. Recent literature warrants more research on evidence
use by policy makers through interaction and personal con-
tacts, relationships within networks and the complexity
and varied context of policy making.
In 2011 the European Commission (EC) funded the
Research into Policy to enhance Physical Activity (REPOPA)
project. One of its aims was to study the extent to which
EU member states use research evidence and other kinds
of evidence in HEPA policies and what promotes or hinders
the uptake of research evidence in the policy-making pro-
cess of HEPA policies [25]. The general aim of the project
was  to facilitate the integration of research evidence to
stimulate more evidence-informed physical activity poli-
cies. The aim, design, methods and preliminary baseline
results of the overall REPOPA—(www.repopa.eu) project
are described by Aro et al. [25]. Preliminary results show
that supportive institutional resources, access to applica-
ble context-relevant research evidence, media attention,
good personal relationships and networks, joint language
and collaboration between researchers and policy mak-
ers were found to facilitate the use of research evidence.
Barriers identiﬁed were related to non-supportive institu-
tional management, lack of easy access to best available
evidence, limited contacts between administrative person-
nel, experts and researchers [25].
The aim of this article is to further explore barriers and
facilitators in the use of research and other evidence in
developing HEPA policies from six EU countries using semi-
structured interviews conducted with key stakeholders as
part of the REPOPA project. More speciﬁcally it focuses on
aspects that (local, regional or national) policymakers and
other stakeholders in different European contexts expe-
rience as most inﬂuencing in the uptake of evidence in
real-life policymaking processes.
2. Methods and design
In the REPOPA project 21 HEPA policies were identiﬁed
across six European countries (Finland, Italy, Romania, UK,
The Netherlands and Denmark) (for details see Ref. [24]).
They varied signiﬁcantly across countries-. The policies
were almost always part of a broader (public) health care or
sports policy. In each country a national and a regional/local
level policy was selected where available (not all coun-
tries had policies at both level). Semi-structured interviews
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were undertaken using a standard topic guide across all
six participating countries. The interviews focused on per-
ceptions and experiences on how research and other types
of evidence, comprising a broad variety of information
sources were used by policymakers [18,29] and what fac-
tors facilitated or hindered their use in the policy making
process. The interviews were conducted by researchers
from the respective countries in their native language.
Each interview took about 1.5-h was tape-recorded and
transcribed (tape-recording was only done when partic-
ipants provided consent), otherwise hand-written notes
were made [26].
By purposeful sampling a total of 86 stakeholders who
were directly involved in the policy making process of
the selected policies and who could inform about the
use of research or other evidence in this speciﬁc policy
making process were identiﬁed and included. The stake-
holders included (national, regional or local) policy makers,
researchers, public sector ofﬁcers or other inﬂuential stake-
holders. All interviewees were contacted by email or phone
by the research team in the country with background
information on the project and consent forms in the local
language [26]. On the (rare) occasion of an identiﬁed
stakeholder was not available for interview, a deputy was
contacted. The interviews were speciﬁcally designed to col-
lect in-depth information on stakeholders experience in
terms of facilitators and barriers in the uptake of evidence
in the everyday world of policy making.
The data collected were analysed by each country team
using a common guideline for qualitative content analy-
sis (analysis were carried out manually or using software
packages for qualitative research such as NVivo, MaxQ-
data). Coding was done by two researchers independently
from each other in the country teams [26]. Each country
produced a report presenting its ﬁndings which were inte-
grated into a single (internal) project report in English.
From the country reports, lists of facilitators and barri-
ers identiﬁed for the use of research evidence were grouped
and categorized using an online concept map  tool [30]. The
concept map  tool helped ﬁnd associations and pull together
similar items and separate differing items mentioned in all
the interviews. By using the concept map  tool the quali-
tative data from interviews formed a pattern of facilitators
and barriers for the use of research evidence in HEPA policy
making. Since the focus was not on ﬁnding differences in
views of different stakeholder groups, overall views were
taken together in the categorization and no weighting of
data was carried out.
REPOPA developed an Ethics Road Map  and Ethics
Guidance Document to coordinate varying national ethics
clearance procedures in partner countries. Ethics clearance
was done in each country according to country-speciﬁc
regulations and procedures (for details see Ref. [31]:
Edwards et al.); however, irrespective of each country’s
requirements, informed consent was obtained from all par-
ticipants. Ethical Committees for each country included
were as follows: Ethics Committee of the Region of South
Denmark and the National Data protection Agency (DK);
Central Committee on Research Involving Human Subjects
(NL); Research Ethical Committee of the National Health
and Welfare Institute (FI); Ethics Committee of the Uni-
versity of Babes-Bolyai (RO); National Research Council
Research Ethics and Bioethics Advisory Committee (IT);
Health and Social Sciences Review Board of University of
Ottawa (CA); Ethics approval by the Research Councils UK
(UK).
The ethical clearance papers of all countries were
approved by the EC before start of the project. The EC had
oversight of the ethics of the overall project.
3. Results
Fig. 1 presents an overview of the facilitators and
barriers for the use of evidence in the policy develop-
ment process highlighted by the interviewees. Although
facilitators and barriers were to some extent in itself com-
plementary, the results presented here show those factors
that interviewees recognized as being mainly facilitating or
mainly hindering in their real world policy making expe-
rience. Factors found to facilitate or hinder the use of
evidence can be categorized into three main domains:
• Domain 1-organizations, systems and infrastructure;
• Domain 2-access and availability of relevant evidence;
• Domain 3-networking and collaboration between
researchers and policy makers.
In addition factors that appeared speciﬁc within the
country or policy context are described.
3.1. Domain 1: organizations, systems and infrastructure
Within the domain of organizations, systems and
infrastructure the following facilitating factors were most
frequently mentioned. Support of administration, which
included the organizations’ structure, resources, systems,
staff and their skills (Fig. 1 upper left), positive attitudes
from managers, setting clear cut criteria for how the pol-
icy process should evolve, close monitoring of the process
and training of personnel in the use of evidence in policy
making.
“My  experience from local level is that the management is
concerned with a high level of professionalism. . ..  . . hence
the fact that we have the (professional) capacity as well
as a management concerned with evidence based policy
making (Local policymaker, Denmark).”
In addition some interviewees mentioned the role of
media. Evidence from traditional media sources such as
television and newspaper articles, but also relatively new
sources such as social media (blogs, internet and twitter)
were felt to have a substantial impact through framing the
problem and its potential solutions by providing exposure
for decision makers.
“Yes, I have the idea that it [priorities] also comes from
the citizens, sometimes because of what is mentioned in
the newspapers and sometimes it is also what the minister
of state has experienced him- or herself (National policy-
maker, Netherlands)”
Barriers which were most frequently mentioned were
the lack of simultaneity between research and policy mak-
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Fig. 1. Overview of facilitators and barriers for the use of evidence in HEPA policy making as mentioned by interviewees.
ing (Fig. 1 upper right), lack of resources (Fig. 1 lower
right), ﬁnancial and time constraints, and the fact that
research evidence hardly ever is directly applicable in pol-
icy within the tight political timeframe. In addition, lack of
staff competences and factors related to ‘relevant research
achievable’ were mentioned (Fig. 1 middle left). A regu-
larly updated, well-functioning research infrastructure was
mentioned as a basic precondition.
3.2. Domain 2: access to and availability of relevant
evidence
In the second domain often mentioned hindering factors
were inapplicability of evidence because of its complex-
ity, extensiveness or being too theoretical (Fig. 1 upper
right). Also the lack of direct relevance was mentioned fre-
quently because often policy makers face situations where
research evidence does not comprise information on (eco-
nomic) impact and costs on concrete policy measures, or
on the speciﬁc local problem or policy context.
“Evaluating national policy in a systematic way  leaves
room for improvement so to speak. . . ..  Of course the Court
of Auditors prioritizes this continuously. They put this lack
of evaluative information on national policy expenditures
on the agenda continuously. . . (National policy advisor,
Netherlands).”
“If we should work evidence based we should not be
doing anything as there is no evidence we can trans-
late . . .directly to municipal context. (Local policy maker,
Denmark).”
“Starting with 2001 there is no research conducted [in
HEPA domain] because of lack of funding. Instead, we use
annual reports from county level representatives, obser-
vations, and population participation rates and expressed
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preferences [for guiding our work].  . . The efﬁcacy indica-
tors from the National Program cannot be evaluated due
to lack of data. (Local policy advisor, Romania).”
Some interviewees stressed the importance of the avail-
ability of tools and methodologies in order to get timely,
concrete and practically applicable evidence, namely tai-
lored research evidence. However, funds especially at local
level appeared limited.
“I can no longer pay for a scientiﬁc advice. It is not only
a funding problem, but also a normative problem: the law
does not allow me to ask for advice. (Local policy maker,
Italy).”
3.3. Domain 3: networking and collaboration between
researchers and policy makers
The third domain is about factors related to networking
and collaboration between researchers and policy makers,
which were often mentioned as potential facilitators for
evidence use (Fig. 1 lower left). More speciﬁcally, creating
cross sector cooperation, seminars and conferences where
researchers and policymakers could meet in order to facil-
itate building a joint language and reference framework.
“..that one can participate in a half- or full-day conference
and yes, listen to results and conclusions being presented
while I also get the opportunity to discuss my own expe-
rience, that’s how it becomes a platform you can indeed
stand up on (Local policy maker, Denmark).”
“Academics do not accept not to be protagonists. Vice versa,
policy makers believe the world is only what they see. A
neutral place would weaken the sense of supremacy of the
two parts. There must exist a neutral place in which each
one feels less self-referential and accept peer discussion
(Local policy maker, Italy).”
Similarly, direct and frequent face-to-face interactions
between researchers and policy makers and working
together as early as possible in policy-related research
projects were mentioned as facilitators for improving
mutual understanding.
“If there would be clear and applicable research studies,
that would allow decision makers to understand the ways
using the results could be beneﬁcial, then decision mak-
ers would be open [to use these studies]. Otherwise, if the
studies are encrypted in a scientiﬁc language; they will only
remain on paper (National policy maker, Romania).”
“We  based our policy on facts, not opinions. We  used inter-
national research results, but also data from the research
projects on the national level and information produced by
research institutions in various research projects. In addi-
tion, we beneﬁted from individual researchers and their
knowledge on speciﬁc research results in Finland or else-
where (National policy maker, Finland).”
Interviewees also mentioned personal liaisons or ‘link-
ing pins’ between knowledge institutes and policy making
organizations as facilitators. Working closely together in
various ways facilitates balancing the uptake of evidence
stemming from research and other types of evidence, like
‘best practices’ and ‘common sense’ or ‘what works by
intuition’ type of knowledge. This also relates to how the
political relevance of (research) evidence is valued (Fig. 1
upper right). In the case that political interests (because of
pursuit of voters, political values) and scientiﬁc evidence do
not complement each other, it may  lead to compromises to
the extent to which (research) evidence uptake occurs.
“I don’t know if I really want to say this, but there wasn’t
any evidence to say that we could do it. It was actually
an aspiration and an absolute belief by the bid team in
particular about ’We  can’ (National policy maker, UK).”
This seems especially relevant because personal char-
acteristics, interests and values of all stakeholders (policy
makers, researchers and politicians) were mentioned by
some as important as to whether individuals actually show
‘a will to cooperate’ and are open to discuss the use of
evidence in policymaking at all.
“In the very beginning it was very difﬁcult to get involved
stakeholders to come together to prepare a joint paper on
nutrition and physical activity. The fear was that the sig-
niﬁcance, the amount of resources and entity of physical
activity as its own issue would be decreased if nutrition
is in the same policy e.g. at the same sandbox sharing the
sand cakes with physical activity’ (National policy maker,
Finland).”
3.4. Country and context speciﬁc factors
The analysis also revealed some ﬁndings as to how barri-
ers and facilitators appeared speciﬁc to the country context.
Political relevance of the issue at stake and media sensitiv-
ity is mentioned in UK, Denmark and Dutch cases as being
quite inﬂuential. Media can inﬂuence political prioritizing
and agenda setting. It also helps create research friendly
trends by making policy decisions more transparent to the
public.
The example of the sports policy linked to the Olympic
Games in London 2012 illustrated that regardless of ample
research evidence, a contextual factor such as political
will in large part determined whether and how this evi-
dence was used. The conclusion from the interviewees in
this respect was: politics decided whether or not a cer-
tain program or policy is launched, independent from what
research evidence suggested [32,33]. Politicians simply felt
that they had to try (because they had a hunch that it might
work) and that London 2012 Olympic Games could inspire
a generation to take up sport. This idea had already been
accepted despite the fact that research evidence from other
countries where this already had been tried before [26,27]
clearly showed a lack of success in motivating the general
public by an Olympic Games policy initiative.
The Finnish policy cases also showed that there was
no lack of available evidence as such, on the contrary,
there was  plenty of evidence available, however, evidence
uptake in policymaking appeared to depend mainly on
personal enthusiasm, willingness, competences and per-
ceived needs of policy professionals. Despite the abundant
availability of evidence on HEPA policy issues, restraints in
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time, resources and competencies withhold policy ofﬁcers
from evaluating and implementing all this information.
When evidence was used it mostly stemmed from direct
(personal) relationships between researchers and policy-
makers, that by the way in Finland were present quite often.
The Dutch and Danish cases were similar to the extent
that HEPA policies are mainly locally initiated and imple-
mented. The Danish cases focused on the local and regional
level only (no national HEPA policy) while the Dutch
case had a general national umbrella policy, however the
Dutch HEPA policymaking was carried out at municipal-
ity level. Both cases showed that locally relevant and
directly usable evidence appeared to be what stakeholders
were lacking mostly. Despite a well-functioning national
research infrastructure in both countries, municipality pol-
icy ofﬁcers appeared to lack practical information on for
example cost-effectiveness and concrete interventions or
policy measures ﬁtting the actual local context and prob-
lems. In the Netherlands the distance (created by law)
between national level policy ambitions and the imple-
mentation of local policy was mentioned to hinder uptake
of evidence. Trust based (personal) relations between
researchers, policy advisors and policymakers at local level
were mentioned in both cases as facilitating the use of evi-
dence.
The lack of concreteness and relevance of evidence to
the local context was mentioned by Italian interviewees
as an important barrier for use of evidence in policy. The
Italian case also showed incomprehensibility and difﬁ-
culty to understand evidence as a key barrier. Translation
and synthesis of the evidence and organizing meetings
between researchers, policymakers and other stakehold-
ers so that (personal) relationships and networks could be
established, were seen as main facilitators.
Finally the Romanian cases showed how a country’s
national and local administrative context is of speciﬁc inﬂu-
ence on the uptake of evidence in policy. It showed that in
Romania a conjunction of empirical, experience grounded
evidence and available resources and opportunities at local
level were leading in HEPA policymaking, as research
evidence appeared not available or not of interest to poli-
cymakers as it was judged to be policy irrelevant. Romania
differed from the other ﬁve countries in that there was
little information available on how the policy was  being
developed, which stakeholders were involved and to what
extent. Interviewees were also difﬁcult to reach or were
not willing to participate and the literacy level regarding
evidence-informed policy making and related terminol-
ogy of the interviewees was rather low. The stakeholders
that participated mentioned that in general, research evi-
dence was lacking and that the evidence that was available
was mostly not relevant to the speciﬁc policy context and
therefore not very useful for implementation. However,
one interviewee mentioned that the research evidence that
was available such that from PhD theses lacked visibility
or political interest and was therefore not used. In addi-
tion policymakers not being used to including evidence
in their work and the lack of ﬁnancial resources at local
level were mentioned as speciﬁc barriers. To compensate
this lack of concrete (research) evidence, other information
such as direct (ﬁeld) observations (e.g. ﬁeld visits), expe-
riences from previously implemented programs and local
level practitioners’ feedback was used.
4. Discussion
This article presents ﬁndings from semi-structured
interviews with 86 stakeholders involved in the policy
development of 21 HEPA policies from national, regional or
local levels in six EU countries. Factors hindering or facili-
tating use of evidence in real-life policy making processes
were explored and analysed. Barriers and facilitators men-
tioned most frequently were categorized into three general
domains: organizations, systems and infrastructure; access
and availability of relevant evidence; and networking and
collaboration between researchers and policy makers. Fur-
ther speciﬁcs of how barriers and facilitators appeared to
interact with country or policy contexts were described.
This study conﬁrms that most of what is already known
from recent literature on key hindrances in uptake of
evidence in policy making in mostly English speaking coun-
tries, also holds true for other European countries. Besides
this ﬁnding which is based on a substantial number of
interviews in 6 European countries, we also found contex-
tual differences in the country cases. Firstly, some cases
showed that the attitude of media towards underpin-
ning policy with evidence (as done in television debates,
newspapers, social media) as well as the political con-
text in which policymaking takes place inﬂuences evidence
uptake in policy. Policy decision makers (e.g. politicians)
may  feel that the media’s attitude has a large impact on
voters and therefore act accordingly. Reviews in the liter-
ature on barriers and facilitators in the use of evidence to
develop health policy mainly focus on factors inﬂuencing
researchers, practitioners and policy ofﬁcers as main stake-
holders. Media appear not to play a substantial role among
these factors [34,15,35,36,10]. Orton et al. [10] do mention
aspects such as political viability and degree of commu-
nity support as non-evidentiary factors of inﬂuence on
policy making. Media engagement can of course strongly
affect these aspects. The fact that we  found stakeholders
explicitly mention that media has an impact on decision
makers’ opinions on the use of evidence adds new insight
to this knowledge. In addition, the rapid development of
social media makes its inﬂuence on the uptake of evidence
hard to ﬁnd in recent literature which makes it even more
relevant. These ﬁndings indicate that the tactical or polit-
ical model of evidence utilization in public health policy
resembles reality more closely than the problem-solving
or knowledge-driven model [16,37,38,39].
Secondly, personal characteristics of both users and
providers of evidence as well as their relationships were
highlighted as being important. Skills, attitudes and values
of individual policy makers (national and local level) and
their ‘will to cooperate’ have an impact on the extent to
which they will access and use available evidence. Oliver
et al. stated that improved skills [15] and building personal
relationships with researchers [18] are important facili-
tators for evidence uptake. Other research showed that
decision makers’ own experiential knowledge impedes the
direct inﬂuence of research evidence in a study of evi-
dence use among UK policy makers [40]. The importance
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of ‘individual factors’ is also known in the research liter-
ature to play a crucial role in the knowledge conversion
process [41,16,10]. Our results also seem to be consis-
tent with the ‘interaction explanation’ according to which
‘knowledge utilization depends on disorderly interactions
between researchers and users’ and interactions across the
interface between policy makers and researchers which
are important to the transfer of evidence to policy [42,34].
Decision makers’ e.g. politicians’ personal beliefs and per-
ceptions as well as cultural circumstances and traditions
in appreciating evidence or more system oriented limi-
tations will always interact with the mere availability or
transferring of research evidence [39,43].
In addition, structural partnerships with all stakehold-
ers generating evidence emerging from active two way
partnerships between researchers, policy decision makers,
funders and other stakeholders and therefore contextu-
ally embedded from the outset, in which evidence is made
synthesized or translated into ‘easier to understand and
applicable evidence’ may  offer potential beneﬁt [49,50].
Thirdly, our study showed that actual use of evidence
requires both optimal policy relevance, which in some
countries needs to be locally embedded. A more personal
and trust based interaction between researchers and (local)
policy makers is also required. Having evidence at hand on
when and where it ﬁts the phase and context of policy-
making, in particular evidence on costs and consequences
of concrete policy measures and interventions, was shown
to support use of evidence in policy making. Although
a lot of valuable work is being done in this respect by
national and international institutions [56,57], policymak-
ers still appeared to experience a lack of evidence especially
on cost effectiveness and implementation of interventions
to the local or regional context. This is also acknowl-
edged in literature where timely access to good quality
and relevant research evidence and interactions across the
interface of research and policy-making are reported to be
the most important factors in inﬂuencing use of evidence
[15,34,12,39].
4.1. Strengths and limitations
In this study HEPA policies from different levels in six
EU member states were included. This can be considered
both a strength and a limitation. A strength since a large
variety of countries and stakeholders involved increased
the possibilities for gathering and exploring the whole con-
tinuum of potential barriers and facilitators that play a role
throughout different contexts and on different levels of pol-
icymaking. Selecting policies from different policy contexts
offered a possibility to learn from different policy making
systems across EU member states. Although the data stem
from 2012, ﬁndings are relevant as policy processes are
long (4–10 years) and dependant on elections and admin-
istrative underpinnings that are still in force. Our ﬁndings
therefore can potentially inform next policymaking cycles.
In addition, having different stakeholder groups involved,
with researchers being a minority, can be seen as a strength
[15]. This study on the one hand offers a vast amount of rich
data in its variety and representation. It spans across dif-
ferent political and social contexts that warrants analytic
generalization [38,44]. While on the other hand, it leaves
little room for strict comparison, which can be seen as a
limitation. This is illustrated by the participation of Roma-
nia for instance. Romania is a highly centralized country
compared to other EU member states that participated in
this research project [39]. Therefore the development of
HEPA policies in Romania mainly takes place at national
level and within a single sector (i.e. the sport sector) [45].
This national political and administrative context mainly
resulted in less articulated information on barriers and
facilitators in cross sector policy making in Romania. In
general, the barriers and facilitators mentioned in Roma-
nia reﬂect similar aspects such as lack of relevant evidence
for policy, although focusing more on implementation of
programs than on HEPA policy development processes. A
further strength is that the interviewees were chosen for
being actually involved in the process of development of
selected HEPA policies. This made their responses real life
based rather than theoretical policy process. This is con-
sidered a major strength because our ﬁndings add to the
existing literature with new information on the barriers
and facilitators that stakeholders experience in the every-
day policy making processes.
4.2. Recommendations
For all the barriers and facilitators identiﬁed in this
study, recommendations can be formulated. With respect
to organizations, systems and infrastructure, structural fac-
tors within the policy makers’ organization create a strong
potential for accelerating research evidence uptake. How-
ever, to enhance evidence uptake more attention needs to
be paid to social and personal factors. The role of managers
[18], relationships and networks in which researchers and
decision makers act [20,19] as well as improved skills of
policy makers can make a clear difference in the extent
of evidence uptake in the policy process [28,10,58]. Also
both researchers and policy makers should be more aware
of how media impact research utilization by inﬂuencing
politicians and how to make better use of its impact. ‘Fram-
ing’ of a problem is one of the ways policy makers and
politicians try to reduce ambiguity and uncertainty of a
speciﬁc problem. Researchers can support policymakers
with providing evidence to support this process of fram-
ing [59]. In addition, more timely interaction, collaboration
and promoting trust based interactions across the interface
between policymakers and researchers could facilitate use
of research evidence by bringing about a joint language,
more mutual understanding of each other’s norms, values
and everyday life realities [15,34,46]. And ﬁnally the con-
textual relevance is a main aspect of how the applicability
of evidence is valued. Therefore, researchers need to be
able to convince policymakers ‘that this works in this pol-
icy context’ with the evidence they provide. They need to
do it such that attitudes and ideologies of decision makers,
their skills and personal values are known and taken into
account; otherwise research evidence will not be taken into
consideration.
Furthermore, research should focus on interventions
that bring researchers and policy makers closer together.
It can start with interventions intensifying contact, collab-
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oration and understanding between different stakeholders
such as stewardship-based intervention [47] and policy
games [48]. One should be aware of the importance to
keep off researchers’ independence and academic freedom
[51–53,11]. In that respect, the role of ‘pivotal’ people who
can inspire and trigger the policy making process and an
enhanced functioning of knowledge brokers may  be stud-
ied further [54]. Knowledge brokers were shown to have a
positive effect in organizations that are not very evidence
oriented [55]. Furthermore, it seems equally important that
researchers, policy makers, politicians and media-ofﬁcers
learn about each other’s realities and the different obsta-
cles they are facing. This will help increase evidence to
be experienced as ‘relevant’ among different stakehold-
ers and consequently will enhance evidence being used
in policy, thus ultimately resulting in more effective pub-
lic health policy. Our study results therefore urge for
interventions that support more structural and personal
interaction between all stakeholder groups throughout the
entire policy making process in generating, interpreting
and discussing the evidence needed to optimally inform
public health policy in different contexts.
Conﬂict of interest
Authors declared no conﬂict of interest.
Acknowledgements
The Research into Policy into Physical Activity (REPOPA)
has received funding by the European Union Seventh
Framework Program (FP7/2007-2013); grant agreement
no. 281532. This document reﬂects only the authors’ views
and neither the European Commission nor any person on
its behalf is liable for any use that may  be made of the
information contained herein.
References
[1] Macintyre S. Evidence based policy making: impact on health
inequalities still needs to be assessed. British Medical Journal
2003;326:5–6.
[2] Rose G. The Strategy of Preventive Medicine. Oxford University Press;
1992.
[3] Oxman AD, Lavis JN, Lewis S, Fretheim A. Support tools for evidence-
informed health policy making: What is evidence informed policy
making? Health Research Policy and Systems 2009;7(Suppl. 1):S1.
[4] Brownson RC, Fielding JE, Maylahn CM.  Evidence-based public
health: a fundamental concept for public health practice. Annual
Review of Public Health 2009;30(April):175–201.
[5] Balas EA, Boren SA, Hicks LL, Chonko AM,  Stephenson K. Effect of
linking practice data to published evidence: a randomized con-
trolled trial of clinical direct reports. Medical Care 1998;36(January
(1)):79–87.
[6] Huckson S, Davies J. Closing evidence to practice gaps in emergency
care: the Australian experience. Academic Emergency Medicine
2007;14(November (11)):1058–63.
[7] Lomas J. Connecting research and policy. Canadian Journal of Policy
Research 2000;1(1):140–4.
[8] McCaughey D, Bruning NS. Debate Rationality versus real-
ity: the challenges of evidence-based decision making for
health policy makers. Implementation Science 2010;5(May),
http://dx.doi.org/10.1186/1748-5908-5-39.
[9]  Liverani M,  Hawkins B, Parkhurst JO. Political and institutional inﬂu-
ences on the use of evidence in public health policy. A systematic
review. PLoS One 2013;8(October (10)):e77404.
[10] Orton L, Lloyd-Williams F, Taylor-Robinson D, O’Flaherty M,
Capewell S. The use of research evidence in public health deci-
sion  making processes: systematic review. PLoS One 2011;6(July
(7)):e21704, http://dx.doi.org/10.1371/journal.pone.0021704.
[11] Shine KT, Bartley B. Whose evidence base? The dynamic effects of
ownership, receptivity and values on collaborative evidence-
informed policy making. Evidence & Policy: A Journal of
Research, Debate and Practice 2011;7(November (4)):511–30,
http://dx.doi.org/10.1332/174426411x603489.
[12] Innvær S, Vist G, Trommald M,  Oxman A. Health policy-makers’ per-
ceptions of their use of evidence: a systematic review. Journal of
Health Services Research & Policy 2002;7(October (4)):239–44.
[13] Larsen M,  Gulis G, Pedersen KM.  Use of evidence in local pub-
lic health work in Denmark. International Journal of Public Health
2012;57(June (3)):477–83.
[14] Lavis JN, Oxman AD, Lewin S, Fretheim A. SUPPORT Tools
for evidence-informed health Policymaking (STP). Health
Research Policy and Systems 2009;7(December (Suppl. 1)):I1,
http://dx.doi.org/10.1186/1478-4505-7-S1-S3.
[15] Oliver K, Innvar S, Lorenc T, Woodman J, Thomas J. A systematic
review of barriers to and facilitators of the use of evidence by pol-
icymakers. BMC Health Services Research 2014;14(January (1)):1,
http://dx.doi.org/10.1186/1472-6963-14-2.
[16] Bowen S, Zwi  AB. Pathways to evidence-informed policy and prac-
tice: a framework for action. PLoS Medicine 2005;2(May (7)):e166.,
http://dx.doi.org/10.1371/journal.pmed.0020166.
[17] Moore G, Redman S, Haines M,  Todd A. What works to increase
the  use of research in population health policy and programmes: a
review. Evidence & Policy: A Journal of Research, Debate and Practice
2011;7(August (3)):277–305.
[18] Oliver KA, de Vocht F. Deﬁning ‘evidence’in public health: a survey of
policymakers’ uses and preferences. The European Journal of Public
Health 2015;(July):ckv082.
[19] Oliver K, de Vocht F, Money A, Everett M.  Who  runs public health? A
mixed-methods study combining qualitative and network analyses.
Journal of Public Health 2013;(April):fdt039.
[20] Shearer JC, Dion M,  Lavis JN. Exchanging and using research evidence
in health policy networks: a statistical network analysis. Implemen-
tation Science 2014;9(October (1)):1.
[21] Armstrong R, Waters E, Dobbins M,  Anderson L, Moore L, Petticrew
M,  Clark R, Pettman TL, Burns C, Moodie M, Conning R. Knowledge
translation strategies to improve the use of evidence in public health
decision making in local government: intervention design and imple-
mentation plan. Implementation Science 2013;8(October (1)):1.
[22] Oliver KA, de Vocht F, Money A, Everett M.  Identifying public
health policymakers’ sources of information: comparing survey
and network analyses. The European Journal of Public Health
2015;(July):ckv083.
[23] Daugbjerg SB, Kahlmeier S, Racioppi F, Martin-Diener E, Martin B,
Oja P, et al. Promotion of physical activity in the European region:
content analysis of 27 national policy documents. Journal of Physical
Activity & Health 2009;6(November (6)):805.
[24] Jansen MW,  De Leeuw E, Hoeijmakers M,  De Vries NK. Working at the
nexus between public health policy, practice and research. Dynamics
of  knowledge sharing in the Netherlands. Health Research Policy and
Systems 2012;10(October):33.
[25] Aro AR, Bertram M,  Hämäläinen RM,  van de Goor I, Skovgaard T,
Valente A, et al. Integrating research evidence and physical activ-
ity policy making—REPOPA project. Health Promotion International
2015;(February):dav002, http://dx.doi.org/10.1093/heapro/dav002.
[26] Hämäläinen RM,  Aro AR, van de Goor I, Lau CJ, Jakobsen
MW,  Chereches RM,  et al. Exploring the use of research
evidence in health-enhancing physical activity policies.
Health Research Policy and Systems 2015;13(October (1)):43,
http://dx.doi.org/10.1186/s12961-015-0047-2.
[27] Eklund Karlsson L, Jakobsen M,  Heiberg W,  Aro AR. Involvement of
external stakeholders in local health policymaking process: a case
study from Odense Municipality Denmark. Evidence & Policy 2016,
http://dx.doi.org/10.1332/174426416x14609162710134.
[28] Aro AR, Smith J, Dekker J. Contextual evidence in clinical medicine
and health promotion. The European Journal of Public Health
2008;18(December (6)):548–9.
[29] Flitcroft K, Gillespie J, Salkeld G, Carter S, Trevena L. Getting evidence
into policy: the need for deliberative strategies? Social Science &
Medicine 2011;72(April (7)):1039–46.
[30] Novak JD, Can˜as AJ. The theory underlying concept maps
and how to construct and use them. Technical Report
IHMC CmapTools 2006-01 Rev 01-2008. Florida Institute
I. van de Goor et al. / Health Policy 121 (2017) 273–281 281
for Human and Machine Cognition. 2008 January 22. avail-
able at: http://cmap.ihmc.us/Publications/ResearchPapers/
TheoryUnderlyingConceptMaps.
[31] Edwards N, Viehbeck S, Hämäläinen R-M, Rus D, Skovgaard T, van de
Goor I, et al. Challenges of ethical clearance in international health
policy and social sciences research: experiences and recommen-
dations from a multi-country research programme. Public Health
Reviews 2012;34(January (1)):1.
[32] Mahtani KR, Protheroe J, Slight SP, Demarzo MM,  Blakeman T,
Barton CA, et al. Can the London 2012 Olympics ‘inspire a gen-
eration’ to do more physical or sporting activities? An overview
of systematic reviews. BMJ  Open 2013;3(January (1)):e002058,
http://dx.doi.org/10.1136/bmjopen-2012.
[33] McCartney G, Thomas S, Thomson H, Scott J, Hamilton V, Hanlon P,
et  al. The health and socioeconomic impacts of major multi-sport
events: systematic review (1978–2008). BMJ  2010;340(May):c2369,
http://dx.doi.org/10.1136/bmj.c2369.
[34] Hanney SR, Gonzalez-Block MA,  Buxton MJ,  Kogan M.  The util-
isation of health research in policy-making: concepts, examples
and methods of assessment. Health Research Policy and Systems
2003;1(January (1)):2.
[35] Wallace J, Nwosu B, Clarke M.  Barriers to the uptake of evidence from
systematic reviews and meta-analyses: a systematic review of deci-
sion makers’ perceptions. BMJ  Open 2012;2(January (1)):e001220,
http://dx.doi.org/10.1136/bmjopen-2012-0012202.
[36]  Lavis J, Davies H, Oxman A, Denis JL, Golden-Biddle K, Ferlie E.
Towards systematic reviews that inform health care management
and policy-making. Journal of Health Services Research & Policy
2005;10(July (Suppl. 1)):35–48.
[37] Nutbeam D. How does evidence inﬂuence public health policy? Tack-
ling health inequalities in England. Health Promotion Journal of
Australia 2003;14(December (3)):154–8.
[38] Weiss CH. The many meanings of research utilization. Public Admin-
istration Review 1979;39(September (5)):426–31.
[39] Petticrew M, Whitehead M,  Macintyre SJ, Graham H, Egan M.  Evi-
dence for public health policy on inequalities: 1: the reality according
to  policymakers. Journal of Epidemiology and Community Health
2004;58(October (10)):811–6.
[40] Elliott H, Popay J. How are policy makers using evidence? Models of
research utilisation and local NHS policy making. Journal of Epidemi-
ology and Community Health 2000;54(June (6)):461–8.
[41] Gubbins C, Corrigan S, Garavan TN, O’Connor C, Leahy D, Long D,
et  al. Evaluating a tacit knowledge sharing initiative: a case study.
European Journal of Training and Development 2012;36(November
(8)):827–47.
[42] Landry R, Lamari M,  Amara N. The extent and determinants of the
utilization of university research in government agencies. Public
Administration Review 2003;63(March (2)):192–205.
[43] Best A, Holmes B. Systems thinking, knowledge and action: towards
better models and methods. Evidence & Policy: A Journal of Research,
Debate and Practice 2010;6(May (2)):145–59.
[44] Polit DF, Beck CT. Generalization in quantitative and qualitative
research: myths and strategies. International Journal of Nursing
Studies 2010;47(November (11)):1451–8.
[45] The Romanian Administrative System—French
Inspiration and National Adaptation,
www.publicresearch.ro/library/ﬁles/sistem administrativ
dragos dinca en.pdf.
[46] Glasgow RE, Emmons KM.  How can we increase translation of
research into practice? Types of evidence needed. Annual Review
of Public Health 2007;28(April):413–33.
[47] The Nufﬁeld Council on Bioethics [Internet]. Nufﬁeld
Bioethics. 2016 [cited 21 Dec 2015]. Available from:
http://www.nufﬁeldbioethics.org.
[48] Geurts JL, Duke RD, Vermeulen PA. Policy gaming for strategy and
change. Long Range Planning 2007;40(December (6)):535–58.
[49] Greenhalgh T, Wieringa S. Is it time to drop the ‘knowledge trans-
lation’ metaphor? A critical literature review. Journal of the Royal
Society of Medicine 2011;104(December (12)):501–9.
[50] Armstrong R, Waters E, Roberts H, Oliver S, Popay J. The role and
theoretical evolution of knowledge translation and exchange in pub-
lic health. Journal of Public Health 2006;28(December (4)):384–9,
http://dx.doi.org/10.1093/pubmed/fdl072.
[51] Funtowicz S, Ravetz J. Science for the post-normal age. Futures
1993;25(7):735–55.
[52] Dahl RA. A democratic dilemma: system effectiveness versus citizen
participation. Political Science Quarterly 1994;109(April (1)):23–34.
[53] Sebba J. Getting Research into Policy: the Role of Think Tanks
and Other Mediators. Impact of Social Sciences Blog; 2011
http://eprints.lse.ac.uk/35740.
[54] Choi BC, Pang T, Lin V, Puska P, Sherman G, Goddard M,  et al. Can
scientists and policy makers work together? Journal of Epidemiology
and Community Health 2005;59(August (8)):632–7.
[55] LaRocca R, Yost J, Dobbins M,  Ciliska D, Butt M. The effectiveness of
knowledge translation strategies used in public health: a systematic
review. BMC Public Health 2012;12(September (1)):1.
[56] National Institute for Health and Clinical Excellence. Supporting
Investment in Public Health: Review of Methods for Assessing Cost
Effectiveness, Cost Impact and Return on Investment. Proof of Con-
cept Report. NHS; 2011.
[57] McDaid D, Sassi F, Merkur S. Promising Health, Preventing Disease.
The Economic Case. WHO/OECD, European Observatory on Health
Systems and Policies. McGraw Hill Education. Open University Press;
2015.
[58] Yost J, Dobbins M,  Traynor R, DeCorby K, Workentine S, Greco L. Tools
to support evidence-informed public health decision making. BMC
Public Health 2014;14(July (1)):1.
[59] Cairney P, Oliver K, Wellstead A. To bridge the divide between evi-
dence and policy: reduce ambiguity as much as uncertainty. Public
Administration Review 2016;76(May (3)):399–402.
